CHINA PHARMA HOLDINGS, INC. Property, Plant and Equipment, Gross
CHINA PHARMA HOLDINGS, INC. (CPHI) had Property, Plant and Equipment, Gross of $39.08 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization › Property, Plant, and Equipment, before Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-08-14
- 2026-06-30: Property, Plant and Equipment, Gross $39.08M.
- 2026-03-31: Property, Plant and Equipment, Gross $38.47M.
- 2025-12-31: Property, Plant and Equipment, Gross $37.88M.
- 2025-09-30: Property, Plant and Equipment, Gross $37.47M.
| Period end | Property, Plant and Equipment, Gross | Property, Plant and Equipment, Gross as first filed |
|---|---|---|
| 2026-06-30 | $39.08M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $38.47M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $37.88M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $37.47M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $37.19M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $37.09M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $36.98M 10-K · filed 2026-04-01 | |
| 2024-09-30 | $37.92M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $37.29M 10-Q · filed 2024-08-14 | |
| 2023-12-31 | $37.50M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $37.12M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $36.88M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $38.79M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $38.32M 10-K · filed 2024-04-01 | |
| 2022-09-30 | $37.61M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $39.54M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $41.62M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $41.44M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $40.73M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $40.48M 10-Q · filed 2021-08-13 | |
| 2020-12-31 | $40.06M 10-K · filed 2022-03-30 | |
| 2020-09-30 | $38.64M 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $36.91M 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $39.78M 10-Q · filed 2021-05-14 | $36.39M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $36.61M 10-K · filed 2021-03-26 | |
| 2019-09-30 | $36.06M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $37.09M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $37.99M 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $37.01M 10-K · filed 2020-03-30 | |
| 2018-09-30 | $37.04M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $38.43M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $40.47M 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $39.06M 10-K · filed 2019-03-28 | |
| 2017-09-30 | $38.76M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $37.42M 10-Q · filed 2017-08-14 | |
| 2016-12-31 | $36.47M 10-K · filed 2018-04-02 | |
| 2016-09-30 | $37.86M 10-Q · filed 2016-11-14 | |
| 2016-03-31 | $39.11M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $38.82M 10-K · filed 2017-03-31 | |
| 2015-09-30 | $30.45M 10-Q · filed 2015-12-28 | |
| 2015-06-30 | $32.60M 10-Q · filed 2015-12-28 | |
| 2015-03-31 | $33.23M 10-Q · filed 2015-12-28 | |
| 2014-12-31 | $40.52M 10-K · filed 2016-03-30 | $33.88M 10-Q · filed 2015-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |